Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P810031/S082

Healon PRO, Healon GV PRO and Healon5 PRO Ophthalmic Viscosurgical Devices (OVD)

Johnson & Johnson Surgical Vision, Inc. · Decision date Jul 28, 2026

FDA DECISIONP810031/S082

What did the FDA decide?

FDA records P810031/S082 as a supplement to PMA P810031, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 28, 2026.

FDA approval order statement

to automate several steps on the manufacturing line of the Healon PRO family of products at the current manufacturing site AMO Uppsala AB (Uppsala, Sweden)
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Jul 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P810031/S082
Regulatory pathway
PMA supplement
Product code
LZP
Decision code
OK30
Decision date
Jul 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: AID, SURGICAL, VISCOELASTIC.

Product code
LZP
FDA device class
3

For the original device and its historical approval scope, see PMA P810031. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P810031 · Original PMA

    HEALON, HEALON GV, HEALON5 PRODUCTS SODIUM HYALURONATE OPHTHALMIC VISCOELASTIC DEVICES

  2. P810031/S080 · Related supplement

    Healon EndoCoat PRO Sodium Hyaluronate Ophthalmic Viscoelastic Device (OVD), Healon Duet PRO II Dual Pack Sodium Hya

  3. P810031/S081 · Related supplement

    Healon PRO Sodium Hyaluronate Ophthalmic Viscoelastic Device (OVD); Healon Duet PRO II Dual Pack Sodium Hyaluronate Opht

  4. P810031/S082 received

    Application receipt date recorded by FDA.

  5. P810031/S082 · FDA decision

    30-Day Notice

  6. P810031/S083 · Related supplement

    Healon EndoCoat PRO Sodium Hyaluronate Ophthalmic Viscoelastic Device (OVD); Healon Duet PRO II Dual Pack Sodium Hya

Timeline entries are records held by MedtechLedger for P810031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P810031

Explore the linked device profile

Other records with product code LZP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Johnson & Johnson Surgical Vision, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
31 Technology Dr., Suite 200, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records